Japan, U.S. Said To Propose Split Drug Patent-Term Plan At TPP Talks
This article was originally published in PharmAsia News
Executive Summary
Japan and U.S. negotiators reportedly are discussing a possible proposal to reduce patent periods on pharmaceuticals so the people of most Trans-Pacific Partnership member nations can have earlier access to generics.